Search Results - technology+classifications+%3e+drug+design+and+synthesis

17 Results Sort By:
Taxane anticancer agents, their pharmaceutical compositions and their use
050-9465 Taxane anticancer agents, their pharmaceutical compositions and their use New taxane anticancer compounds designed with carbamate substituents at the C-10 position with lower cytotoxicity and superior potency Background: Despite advances in chemotherapeutic interventions, cancer remains the second largest cause of death in the United States....
Published: 5/7/2026   |   Updated: 5/7/2026   |   Inventor(s): Iwao Ojima, Hersh Bendale, Kalani Jayanetti, Ananya Shibana Thennarasu
Keywords(s):  
Category(s): Technology Classifications > Drug Design and Synthesis, Campus > Stony Brook University
Sterylglucosidase Inhibitors as Antifungal Agents
050-9346 Sterylglucosidase Inhibitors as Antifungal Agents Novel antifungal compounds that function as substrate-mimicking inhibitors of sterylglucosidase for antifungal medication and therapeutics Background: Invasive fungal infections, such as life-threatening meningoencephalitis caused by Cryptococcus neoformans and severe pulmonary aspergillosis...
Published: 5/4/2026   |   Updated: 2/19/2026   |   Inventor(s): Iwao Ojima, Maurizio Del Poeta, Michael Airola, Nivea Pereira de Sa, SeungYoun Shin, Kalani Jayanetti, Dominick Rendina, Ananya Shibana Thennarasu
Keywords(s):  
Category(s): Technology Classifications > Drug Design and Synthesis, Campus > Stony Brook University, Campus
Macrocycle-Based Chelators for Room Temperature Chelation of Radioactive Isotopes
050-9235 Macrocycle-Based Chelators for Room Temperature Chelation of Radioactive Isotopes Ternary complexes that produce robust radiopharmaceuticals with a high radiochemical yield and specific activity for enhanced radiolabeling Background: The management of various cancers, particularly prostate cancer, increasingly relies on targeted radiotherapeutics...
Published: 5/4/2026   |   Updated: 2/13/2026   |   Inventor(s): Eszter Boros, Brett Vaughn, Jennifer Whetter
Keywords(s):  
Category(s): Technology Classifications > Drug Design and Synthesis, Technology Classifications > Medical Imaging, Campus > Stony Brook University
LpxC Inhibitors for Gram-Negative Infections
Treatment of multidrug-resistant bacterial infections with LpxC inhibitors for reduced drug resistance and improved safety profiles RSS.HDBackground> Background: < Infection by Gram‑negative bacteria such as Pseudomonas aeruginosa, β‑lactamase producing (ESBL) Enterobacteriaceae, and Acinetobacter baumannii is a major health problem, especially...
Published: 7/25/2025   |   Updated: 3/7/2025   |   Inventor(s): Peter Tonge, Fereidoon Daryaee, Sneha Basak
Keywords(s):  
Category(s): Campus > Stony Brook University, Technology Classifications > Drug Design and Synthesis
Design and Synthesis of Novel Methotrexate Conjugated MicroRNA Mimic Modified with 5-Fluorouracil and/or Gemcitabine as a Platform Technology for Cancer Treatment
A platform for modifying miRNAs and using the modified miRNAs as novel cancer therapeutics. RSS.HDBackground> Background: < Resistance to chemotherapy can be a highly complex issue, with epigenetic alterations playing a key role in tumorigenesis and chemotherapy resistance. The failure to treat several advanced solid tumors can be often attributed...
Published: 5/14/2026   |   Updated: 3/7/2025   |   Inventor(s): Jingfang Ju, Iwao Ojima, John Yuen, Lei Chen
Keywords(s):  
Category(s): Campus > Stony Brook University, Technology Classifications > Drug Design and Synthesis
Concerted, Selective Radiometallation and Photo-triggered Release of Ready-to-Inject Radiopharmaceuticals from the Solid Phase
Solid Phase Radiometallation Photorelease method for the preparation of injectable radiopharmaceuticals RSS.HDBackground> Background: < Radiopharmaceuticals are agents which enable non-invasive patient diagnosis and personalized therapeutic intervention strategies. Radionuclides used in nuclear medicine applications must be purified after nuclear...
Published: 2/4/2025   |   Updated: 2/3/2025   |   Inventor(s): Eszter Boros, Dariusz Śmiłowicz
Keywords(s):  
Category(s): Technology Classifications > Diagnostics, Campus > Stony Brook University, Technology Classifications > Drug Design and Synthesis
6-azasteroids with unique activity in mycobacteria
The compound functions as potentiators of several anti-tuberculosis drugs RSS.HDBackground> Background: < One third of the world’s population is infected with tuberculosis (TB). In 2014, there were 1.5 million TB related deaths. There are drugs to combat the bacteria by attacking the bacteria directly. The current recommended treatment...
Published: 5/14/2025   |   Updated: 2/3/2025   |   Inventor(s): Nicole Sampson, Joshua Werman, Tianao Yuan
Keywords(s):  
Category(s): Technology Classifications, Campus > Stony Brook University, Technology Classifications > Drug Design and Synthesis
Metal-mediated, Autolytic Amide Bond Cleavage for the Selective, Metal-Complexation Catalyzed, Controlled Release of Metallodrugs
Autolytic, metal complex-mediated amide bond cleavage for prodrug activation and synthesis of metallodrugs RSS.HDBackground> Background: < Clinically viable prodrugs release activated drug molecules at the site of interest, requiring close spatiotemporal control. Bond cleavage strategies for the release of the activated drug often incorporate...
Published: 7/28/2025   |   Updated: 1/30/2025   |   Inventor(s): Eszter Boros, Dariusz Śmiłowicz
Keywords(s):  
Category(s): Technology Classifications > Drug Delivery, Campus, Campus > Stony Brook University, Technology Classifications > Drug Design and Synthesis
Immunostimulant-Cytotoxic Conjugates for Targeted Cancer Therapy
050-9150 Immunostimulant-Cytotoxic Conjugates for Targeted Cancer Therapy A unique immunotherapy paradigm to treat castrate-resistant prostate cancer and its metastatic form RSS.HDBackground> Background: < Prostate cancer is one of the leading causes of cancer death, with 1 in 10 men diagnosed in their lifetime and 1 in 41 dying from the...
Published: 7/25/2025   |   Updated: 8/9/2022   |   Inventor(s): Labros Meimetis, Eszter Boros
Keywords(s): Technologies
Category(s): Technology Classifications > Drug Delivery, Campus > Stony Brook University, Technology Classifications > Drug Design and Synthesis
Enzymatic Capsulotomy for Shoulder Adhesive Capsulitis
A minimally invasive collagenase injection method for treating frozen shoulder that is cost-effective Background: Adhesive capsulitis of the shoulder, more commonly known as frozen shoulder, results in painful limitation of shoulder motion. It can arise idiopathically or after trauma. The current standard of care is a long course of painful physical...
Published: 7/25/2025   |   Updated: 8/27/2020   |   Inventor(s): Marie Badalamente, Edward Wang
Keywords(s): Collagenase Injection, Frozen shoulder, Nonoperative Therapy, Technologies
Category(s): Campus > Stony Brook University, Technology Classifications > Drug Design and Synthesis
1 2